Latest Updates of Viva’s Portfolio Companies
HONG KONG, Sept. 26, 2023 /PRNewswire/ -- Even with the ever-changing situation, technological innovation is still the most critical component for biopharmaceutical companies' long-term development. This continuous innovation keeps companies up to date and promotes the evolution of R&D and the success of commercialization. Recently, Viva's portfolio companies have new updates. Keep reading for more details. AcuraStem Enters into...
China Jo-Jo Drugstores Announces $2.59 Million Registered Direct Offering
HANGZHOU, China, Sept. 26, 2023 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that it has entered into definitive agreements with a number of investors providing for the issuance of 9.96 million ordinary...
Actinogen optimizes XanaMIA Phase 2b Alzheimer’s disease trial design and provides general business update
Highlights Changes to the XanaMIA protocol reduce cost by AUD 30 million over the next two years and speed time to initial results while preserving the 36-week design and trial endpoints. UK sites added to the XanaCIDD trial of cognitive impairment associated with depression, due to report results mid-2024. SYDNEY, Sept....
YS Biopharma Announces First Subject Enrollment in Pivotal Phase 3 Clinical Trial of PIKA Rabies Vaccine
GAITHERSBURG, Md., Sept. 26, 2023 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced that it has enrolled the first subject in its...
World Contraception Day 2023: Bayer Indonesia launches “Bayer For Her” to improve the reproductive health of Indonesian women
Bayer promotes the empowerment of Indonesian women, enabling them to make informed choices on their reproductive health to enhance a better quality of life. JAKARTA, Indonesia, Sept. 26, 2023 /PRNewswire/ -- Coinciding with the commemoration of World Contraception Day 2023, Bayer Indonesia launched the "Bayer for Her" campaign, underscoring the imperative for Indonesian women to take proactive measures to enhance their reproductive health...
WuXi Vaccines Launches Its First Vaccines CDMO Site in China
SUZHOU, China, Sept. 26, 2023 /PRNewswire/ -- WuXi Vaccines, a leading contract development and manufacturing organization (CDMO) focused on vaccine discovery, development, and manufacturing, has launched its first standalone vaccines CDMO site in Suzhou, China. The opening will add drug substance and drug product capacity, with end-to-end services for diversified vaccines that will accelerate global clients' project timelines –...
LONGi reduces the number of people lacking electricity and facilitates energy equity to keep the world with disparities in harmony empowered by light
GENEVA, Sept. 26, 2023 /PRNewswire/ -- Lebanon faces an acute shortage of electricity, and consequently private generators have become a ubiquitous presence on the streets of the country since the 1990s. AL Zaharaa Hospital, one of the largest hospitals in Lebanon, is a comprehensive hospital integrating medical treatment, medical education and medical research. Normally,...
Ascletis Announces Completion of Enrollment of 120 Patients in the Phase III Clinical Trial of FASN Inhibitor ASC40 Combined with Bevacizumab for Treatment of Recurrent Glioblastoma
--Based on prespecified interim analysis condition, 120 patients are likely to lead sufficient events for interim analysis of progression-free survival (PFS) HANGZHOU and SHAOXING, China, Sept. 26, 2023 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") today announces the completion of enrollment of 120 patients in the Phase III registration clinical trial of ASC40 combined with bevacizumab for...
Johnson & Johnson Innovation Announces Collaboration with Singapore Economic Development Board to Help Transform Singapore’s Life Science Innovation Ecosystem
The first-of-its-kind collaboration will embed the services and resources of Johnson & Johnson Innovation - JLABS into Singapore's life science ecosystem to unlock regional innovation potential. SINGAPORE, Sept. 26, 2023 /PRNewswire/ -- Johnson & Johnson International (Singapore) Pte. Ltd. today announced a collaboration with the Singapore Economic Development Board (EDB) to unlock innovation potential in Singapore's life...
Dr.FORHAIR Announces U.S. In-Store Launch of Best Selling Hair Loss Shampoo
Global Scalp Care Brand to Launch Folligen Original Shampoo in 50 U.S. Costco Branches After Being Sold Online LOS ANGELES, Sept. 25, 2023 /PRNewswire/ -- Dr.FORHAIR, a global scalp care brand, has announced the first offline launch of its best selling Folligen Original Shampoo across 50 Costco branches in the U.S, slated for October 1, 2023. This award-winning hair loss...
